Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

10/08/2017 07:00

Aug 10 (Reuters)-  
             Shin Nippon Biomedical Laboratories Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             3.38                3.39             16.25     
                 (-0.4 pct)          (+5.3 pct)       (-5.8 pct)   
  Operating     loss 698 mln        loss 947 mln       loss 1.10   
  Recurring     loss 577 mln          loss 1.80        loss 1.22   
  Net           loss 604 mln          loss 1.78        loss 1.50   
  EPS          loss 14.51 yen      loss 44.21 yen      36.02 yen   
  Ann Div                                NIL                       
  -Q2 div                                NIL                       
  -Q4 div                                NIL                       
   
  NOTE - Shin Nippon Biomedical Laboratories Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T  
  ((Tokyo Headline News Desk +813 6441 1812))